Longitudinal neurodegeneration in Early‐Onset Alzheimer’s Disease: A summary of MRI‐derived atrophy in LEADS

Background Prior work has advanced our understanding of cortical atrophy in early‐onset Alzheimer’s disease (EOAD), but longitudinal data are sparse. Current longitudinal MRI studies point to progressive atrophy in cerebral cortex exhibiting a posterior‐to‐anterior gradient, but these studies includ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alzheimer's & dementia 2024-12, Vol.20 (S2), p.n/a
Hauptverfasser: Touroutoglou, Alexandra, Katsumi, Yuta, Eckbo, Ryan, Brickhouse, Michael, Eloyan, Ani, Nudelman, Kelly N., Foroud, Tatiana M., Dage, Jeffrey L., Carrillo, Maria C., Rabinovici, Gil D., Apostolova, Liana G., Dickerson, Bradford C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue S2
container_start_page
container_title Alzheimer's & dementia
container_volume 20
creator Touroutoglou, Alexandra
Katsumi, Yuta
Eckbo, Ryan
Brickhouse, Michael
Eloyan, Ani
Nudelman, Kelly N.
Foroud, Tatiana M.
Dage, Jeffrey L.
Carrillo, Maria C.
Rabinovici, Gil D.
Apostolova, Liana G.
Dickerson, Bradford C.
description Background Prior work has advanced our understanding of cortical atrophy in early‐onset Alzheimer’s disease (EOAD), but longitudinal data are sparse. Current longitudinal MRI studies point to progressive atrophy in cerebral cortex exhibiting a posterior‐to‐anterior gradient, but these studies include small samples with mostly amnestic EOAD. Here, we analyzed a large sample of sporadic EOAD patients from the Longitudinal Early‐Onset Alzheimer's Disease Study (LEADS) to test the central hypothesis that areas in our recently described EOAD signature (Touroutoglou et al., 2023) affected at baseline in the posterior lateral temporal cortex, inferior parietal lobule, and PCC/precuneus will continue to degenerate and additional longitudinal atrophy will be found in the medial temporal lobe and frontal regions as cognitive decline progresses over time in multiple domains. Method We investigated longitudinal changes in cortical thickness by analyzing structural MRI data collected from 367 patients with EOAD and 99 cognitively unimpaired (CN) older adults, totaling 839 MRI scans across the cohorts with up to 4 years of follow‐up. MRI data were longitudinally processed in FreeSurfer 6.0. Linear mixed effects models were constructed to estimate the rate of cortical atrophy with random intercepts and slopes for individual participants while controlling for baseline age and sex. Result EOAD patients exhibited cortical atrophy at a faster rate than controls in widespread areas of the cerebral cortex. As expected, the regions exhibiting accelerated longitudinal atrophy included not only the EOAD signature regions as a whole (EOAD: ‐0.052±0.002 mm/year vs. CN: 0.0001±0.002 mm/year; Dslopes = ‐0.052, p
doi_str_mv 10.1002/alz.091402
format Article
fullrecord <record><control><sourceid>wiley_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11714645</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ALZ091402</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1332-b0e1d5c313894c0c77d8773d55648997f4dc88b5bb292c02487eeb8e4ca616e03</originalsourceid><addsrcrecordid>eNp9kMtKAzEUhgdRsFY3PkHWQmsyk8zFjQxt1cJIwcvGTcgkZ9rINFOSmcp01Udw6-v1SWxpKbhxdQ6c7_84_J53TXCfYOzfinLVxwmh2D_xOoQxv8f8KDk97iE-9y6c-8SY4piwjmezykx13ShtRIkMNLZSMAUDVtS6MkgbNBK2bDfr74lxUKO0XM1Az8Fu1j8ODbUD4eAOpcg187mwLaoK9Pwy3vIKrF6CQqK21WLW7lTZKB2-XnpnhSgdXB1m13t_GL0NnnrZ5HE8SLOeJEHg93IMRDEZkCBOqMQyilQcRYFiLKRxkkQFVTKOc5bnfuJL7NM4AshjoFKEJAQcdL37vXfR5HNQEkxtRckXVu_-5JXQ_O_F6BmfVktOSERoSNnWcLM3SFs5Z6E4hgnmu775tm--73sLkz38pUto_yF5mn0cMr8HCIdP</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Longitudinal neurodegeneration in Early‐Onset Alzheimer’s Disease: A summary of MRI‐derived atrophy in LEADS</title><source>Wiley Online Library - AutoHoldings Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><source>Wiley-Blackwell Open Access Titles(OpenAccess)</source><creator>Touroutoglou, Alexandra ; Katsumi, Yuta ; Eckbo, Ryan ; Brickhouse, Michael ; Eloyan, Ani ; Nudelman, Kelly N. ; Foroud, Tatiana M. ; Dage, Jeffrey L. ; Carrillo, Maria C. ; Rabinovici, Gil D. ; Apostolova, Liana G. ; Dickerson, Bradford C.</creator><creatorcontrib>Touroutoglou, Alexandra ; Katsumi, Yuta ; Eckbo, Ryan ; Brickhouse, Michael ; Eloyan, Ani ; Nudelman, Kelly N. ; Foroud, Tatiana M. ; Dage, Jeffrey L. ; Carrillo, Maria C. ; Rabinovici, Gil D. ; Apostolova, Liana G. ; Dickerson, Bradford C. ; the LEADS Consortium</creatorcontrib><description>Background Prior work has advanced our understanding of cortical atrophy in early‐onset Alzheimer’s disease (EOAD), but longitudinal data are sparse. Current longitudinal MRI studies point to progressive atrophy in cerebral cortex exhibiting a posterior‐to‐anterior gradient, but these studies include small samples with mostly amnestic EOAD. Here, we analyzed a large sample of sporadic EOAD patients from the Longitudinal Early‐Onset Alzheimer's Disease Study (LEADS) to test the central hypothesis that areas in our recently described EOAD signature (Touroutoglou et al., 2023) affected at baseline in the posterior lateral temporal cortex, inferior parietal lobule, and PCC/precuneus will continue to degenerate and additional longitudinal atrophy will be found in the medial temporal lobe and frontal regions as cognitive decline progresses over time in multiple domains. Method We investigated longitudinal changes in cortical thickness by analyzing structural MRI data collected from 367 patients with EOAD and 99 cognitively unimpaired (CN) older adults, totaling 839 MRI scans across the cohorts with up to 4 years of follow‐up. MRI data were longitudinally processed in FreeSurfer 6.0. Linear mixed effects models were constructed to estimate the rate of cortical atrophy with random intercepts and slopes for individual participants while controlling for baseline age and sex. Result EOAD patients exhibited cortical atrophy at a faster rate than controls in widespread areas of the cerebral cortex. As expected, the regions exhibiting accelerated longitudinal atrophy included not only the EOAD signature regions as a whole (EOAD: ‐0.052±0.002 mm/year vs. CN: 0.0001±0.002 mm/year; Dslopes = ‐0.052, p&lt;.001), but also those that were minimally atrophied at baseline, such as superior frontal gyrus (EOAD: ‐0.052+/‐0.004 vs. CN: ‐0.001+/‐0.004, Dslopes = ‐ 0.051, p&lt;.001) and medial temporal lobe (EOAD: ‐0.083±0.005 mm/year vs. CN: 0.001±0.006 mm/year; Dslopes = ‐0.082, p&lt;.001). We observed no difference in the rate of atrophy in the calcarine fissure (a control region not expected to change; Dslopes = ‐0.002, p£.69). Conclusion Our findings show that neurodegeneration in EOAD accelerates over time in the EOAD signature regions and spreads to additional areas within large‐scale brain networks (consistent with those observed in late‐onset AD) contributing to the worsening of symptoms over time.</description><identifier>ISSN: 1552-5260</identifier><identifier>EISSN: 1552-5279</identifier><identifier>DOI: 10.1002/alz.091402</identifier><language>eng</language><publisher>Hoboken: John Wiley and Sons Inc</publisher><subject>Biomarkers</subject><ispartof>Alzheimer's &amp; dementia, 2024-12, Vol.20 (S2), p.n/a</ispartof><rights>2024 The Alzheimer's Association. published by Wiley Periodicals LLC on behalf of Alzheimer's Association.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11714645/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11714645/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,1412,11543,27905,27906,45555,45556,46033,46457,53772,53774</link.rule.ids></links><search><creatorcontrib>Touroutoglou, Alexandra</creatorcontrib><creatorcontrib>Katsumi, Yuta</creatorcontrib><creatorcontrib>Eckbo, Ryan</creatorcontrib><creatorcontrib>Brickhouse, Michael</creatorcontrib><creatorcontrib>Eloyan, Ani</creatorcontrib><creatorcontrib>Nudelman, Kelly N.</creatorcontrib><creatorcontrib>Foroud, Tatiana M.</creatorcontrib><creatorcontrib>Dage, Jeffrey L.</creatorcontrib><creatorcontrib>Carrillo, Maria C.</creatorcontrib><creatorcontrib>Rabinovici, Gil D.</creatorcontrib><creatorcontrib>Apostolova, Liana G.</creatorcontrib><creatorcontrib>Dickerson, Bradford C.</creatorcontrib><creatorcontrib>the LEADS Consortium</creatorcontrib><title>Longitudinal neurodegeneration in Early‐Onset Alzheimer’s Disease: A summary of MRI‐derived atrophy in LEADS</title><title>Alzheimer's &amp; dementia</title><description>Background Prior work has advanced our understanding of cortical atrophy in early‐onset Alzheimer’s disease (EOAD), but longitudinal data are sparse. Current longitudinal MRI studies point to progressive atrophy in cerebral cortex exhibiting a posterior‐to‐anterior gradient, but these studies include small samples with mostly amnestic EOAD. Here, we analyzed a large sample of sporadic EOAD patients from the Longitudinal Early‐Onset Alzheimer's Disease Study (LEADS) to test the central hypothesis that areas in our recently described EOAD signature (Touroutoglou et al., 2023) affected at baseline in the posterior lateral temporal cortex, inferior parietal lobule, and PCC/precuneus will continue to degenerate and additional longitudinal atrophy will be found in the medial temporal lobe and frontal regions as cognitive decline progresses over time in multiple domains. Method We investigated longitudinal changes in cortical thickness by analyzing structural MRI data collected from 367 patients with EOAD and 99 cognitively unimpaired (CN) older adults, totaling 839 MRI scans across the cohorts with up to 4 years of follow‐up. MRI data were longitudinally processed in FreeSurfer 6.0. Linear mixed effects models were constructed to estimate the rate of cortical atrophy with random intercepts and slopes for individual participants while controlling for baseline age and sex. Result EOAD patients exhibited cortical atrophy at a faster rate than controls in widespread areas of the cerebral cortex. As expected, the regions exhibiting accelerated longitudinal atrophy included not only the EOAD signature regions as a whole (EOAD: ‐0.052±0.002 mm/year vs. CN: 0.0001±0.002 mm/year; Dslopes = ‐0.052, p&lt;.001), but also those that were minimally atrophied at baseline, such as superior frontal gyrus (EOAD: ‐0.052+/‐0.004 vs. CN: ‐0.001+/‐0.004, Dslopes = ‐ 0.051, p&lt;.001) and medial temporal lobe (EOAD: ‐0.083±0.005 mm/year vs. CN: 0.001±0.006 mm/year; Dslopes = ‐0.082, p&lt;.001). We observed no difference in the rate of atrophy in the calcarine fissure (a control region not expected to change; Dslopes = ‐0.002, p£.69). Conclusion Our findings show that neurodegeneration in EOAD accelerates over time in the EOAD signature regions and spreads to additional areas within large‐scale brain networks (consistent with those observed in late‐onset AD) contributing to the worsening of symptoms over time.</description><subject>Biomarkers</subject><issn>1552-5260</issn><issn>1552-5279</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><recordid>eNp9kMtKAzEUhgdRsFY3PkHWQmsyk8zFjQxt1cJIwcvGTcgkZ9rINFOSmcp01Udw6-v1SWxpKbhxdQ6c7_84_J53TXCfYOzfinLVxwmh2D_xOoQxv8f8KDk97iE-9y6c-8SY4piwjmezykx13ShtRIkMNLZSMAUDVtS6MkgbNBK2bDfr74lxUKO0XM1Az8Fu1j8ODbUD4eAOpcg187mwLaoK9Pwy3vIKrF6CQqK21WLW7lTZKB2-XnpnhSgdXB1m13t_GL0NnnrZ5HE8SLOeJEHg93IMRDEZkCBOqMQyilQcRYFiLKRxkkQFVTKOc5bnfuJL7NM4AshjoFKEJAQcdL37vXfR5HNQEkxtRckXVu_-5JXQ_O_F6BmfVktOSERoSNnWcLM3SFs5Z6E4hgnmu775tm--73sLkz38pUto_yF5mn0cMr8HCIdP</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Touroutoglou, Alexandra</creator><creator>Katsumi, Yuta</creator><creator>Eckbo, Ryan</creator><creator>Brickhouse, Michael</creator><creator>Eloyan, Ani</creator><creator>Nudelman, Kelly N.</creator><creator>Foroud, Tatiana M.</creator><creator>Dage, Jeffrey L.</creator><creator>Carrillo, Maria C.</creator><creator>Rabinovici, Gil D.</creator><creator>Apostolova, Liana G.</creator><creator>Dickerson, Bradford C.</creator><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>202412</creationdate><title>Longitudinal neurodegeneration in Early‐Onset Alzheimer’s Disease: A summary of MRI‐derived atrophy in LEADS</title><author>Touroutoglou, Alexandra ; Katsumi, Yuta ; Eckbo, Ryan ; Brickhouse, Michael ; Eloyan, Ani ; Nudelman, Kelly N. ; Foroud, Tatiana M. ; Dage, Jeffrey L. ; Carrillo, Maria C. ; Rabinovici, Gil D. ; Apostolova, Liana G. ; Dickerson, Bradford C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1332-b0e1d5c313894c0c77d8773d55648997f4dc88b5bb292c02487eeb8e4ca616e03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Biomarkers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Touroutoglou, Alexandra</creatorcontrib><creatorcontrib>Katsumi, Yuta</creatorcontrib><creatorcontrib>Eckbo, Ryan</creatorcontrib><creatorcontrib>Brickhouse, Michael</creatorcontrib><creatorcontrib>Eloyan, Ani</creatorcontrib><creatorcontrib>Nudelman, Kelly N.</creatorcontrib><creatorcontrib>Foroud, Tatiana M.</creatorcontrib><creatorcontrib>Dage, Jeffrey L.</creatorcontrib><creatorcontrib>Carrillo, Maria C.</creatorcontrib><creatorcontrib>Rabinovici, Gil D.</creatorcontrib><creatorcontrib>Apostolova, Liana G.</creatorcontrib><creatorcontrib>Dickerson, Bradford C.</creatorcontrib><creatorcontrib>the LEADS Consortium</creatorcontrib><collection>Wiley-Blackwell Open Access Titles(OpenAccess)</collection><collection>Wiley-Blackwell Free Backfiles(OpenAccess)</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Alzheimer's &amp; dementia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Touroutoglou, Alexandra</au><au>Katsumi, Yuta</au><au>Eckbo, Ryan</au><au>Brickhouse, Michael</au><au>Eloyan, Ani</au><au>Nudelman, Kelly N.</au><au>Foroud, Tatiana M.</au><au>Dage, Jeffrey L.</au><au>Carrillo, Maria C.</au><au>Rabinovici, Gil D.</au><au>Apostolova, Liana G.</au><au>Dickerson, Bradford C.</au><aucorp>the LEADS Consortium</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Longitudinal neurodegeneration in Early‐Onset Alzheimer’s Disease: A summary of MRI‐derived atrophy in LEADS</atitle><jtitle>Alzheimer's &amp; dementia</jtitle><date>2024-12</date><risdate>2024</risdate><volume>20</volume><issue>S2</issue><epage>n/a</epage><issn>1552-5260</issn><eissn>1552-5279</eissn><abstract>Background Prior work has advanced our understanding of cortical atrophy in early‐onset Alzheimer’s disease (EOAD), but longitudinal data are sparse. Current longitudinal MRI studies point to progressive atrophy in cerebral cortex exhibiting a posterior‐to‐anterior gradient, but these studies include small samples with mostly amnestic EOAD. Here, we analyzed a large sample of sporadic EOAD patients from the Longitudinal Early‐Onset Alzheimer's Disease Study (LEADS) to test the central hypothesis that areas in our recently described EOAD signature (Touroutoglou et al., 2023) affected at baseline in the posterior lateral temporal cortex, inferior parietal lobule, and PCC/precuneus will continue to degenerate and additional longitudinal atrophy will be found in the medial temporal lobe and frontal regions as cognitive decline progresses over time in multiple domains. Method We investigated longitudinal changes in cortical thickness by analyzing structural MRI data collected from 367 patients with EOAD and 99 cognitively unimpaired (CN) older adults, totaling 839 MRI scans across the cohorts with up to 4 years of follow‐up. MRI data were longitudinally processed in FreeSurfer 6.0. Linear mixed effects models were constructed to estimate the rate of cortical atrophy with random intercepts and slopes for individual participants while controlling for baseline age and sex. Result EOAD patients exhibited cortical atrophy at a faster rate than controls in widespread areas of the cerebral cortex. As expected, the regions exhibiting accelerated longitudinal atrophy included not only the EOAD signature regions as a whole (EOAD: ‐0.052±0.002 mm/year vs. CN: 0.0001±0.002 mm/year; Dslopes = ‐0.052, p&lt;.001), but also those that were minimally atrophied at baseline, such as superior frontal gyrus (EOAD: ‐0.052+/‐0.004 vs. CN: ‐0.001+/‐0.004, Dslopes = ‐ 0.051, p&lt;.001) and medial temporal lobe (EOAD: ‐0.083±0.005 mm/year vs. CN: 0.001±0.006 mm/year; Dslopes = ‐0.082, p&lt;.001). We observed no difference in the rate of atrophy in the calcarine fissure (a control region not expected to change; Dslopes = ‐0.002, p£.69). Conclusion Our findings show that neurodegeneration in EOAD accelerates over time in the EOAD signature regions and spreads to additional areas within large‐scale brain networks (consistent with those observed in late‐onset AD) contributing to the worsening of symptoms over time.</abstract><cop>Hoboken</cop><pub>John Wiley and Sons Inc</pub><doi>10.1002/alz.091402</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1552-5260
ispartof Alzheimer's & dementia, 2024-12, Vol.20 (S2), p.n/a
issn 1552-5260
1552-5279
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11714645
source Wiley Online Library - AutoHoldings Journals; PubMed Central; PubMed Central Open Access; Wiley-Blackwell Open Access Titles(OpenAccess)
subjects Biomarkers
title Longitudinal neurodegeneration in Early‐Onset Alzheimer’s Disease: A summary of MRI‐derived atrophy in LEADS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T17%3A38%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Longitudinal%20neurodegeneration%20in%20Early%E2%80%90Onset%20Alzheimer%E2%80%99s%20Disease:%20A%20summary%20of%20MRI%E2%80%90derived%20atrophy%20in%20LEADS&rft.jtitle=Alzheimer's%20&%20dementia&rft.au=Touroutoglou,%20Alexandra&rft.aucorp=the%20LEADS%20Consortium&rft.date=2024-12&rft.volume=20&rft.issue=S2&rft.epage=n/a&rft.issn=1552-5260&rft.eissn=1552-5279&rft_id=info:doi/10.1002/alz.091402&rft_dat=%3Cwiley_pubme%3EALZ091402%3C/wiley_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true